Efg Asset Management (North America) Corp. Ultragenyx Pharmaceutical Inc. Transaction History
Efg Asset Management (North America) Corp.
- $568 Million
- Q1 2024
A detailed history of Efg Asset Management (North America) Corp. transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Efg Asset Management (North America) Corp. holds 116,836 shares of RARE stock, worth $4.79 Million. This represents 0.96% of its overall portfolio holdings.
Number of Shares
116,836
Previous 68,468
70.64%
Holding current value
$4.79 Million
Previous $3.27 Million
66.62%
% of portfolio
0.96%
Previous 0.63%
Shares
5 transactions
Others Institutions Holding RARE
# of Institutions
286Shares Held
78.6MCall Options Held
570KPut Options Held
228K-
Vanguard Group Inc Valley Forge, PA8.7MShares$356 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.09MShares$290 Million5.31% of portfolio
-
Black Rock Inc. New York, NY5.24MShares$214 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA4.1MShares$168 Million0.03% of portfolio
-
Sands Capital Management, LLC Arlington, VA3.86MShares$158 Million0.53% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $2.87B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...